PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Linnan Zhao

First Affiliated Hospital of Zhengzhou University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 7, 2026 · JOURNAL ARTICLE

Identificationof Tumor Hypoxia-Activated Degradation-TargetingChimeras

Journal of Medicinal Chemistry

This is a proof-of-concept chemical synthesis and mechanism study demonstrating a novel drug design strategy in cells and xenografts, lacking clinical endpoints or comparison to standard therapy.

Hypothesis-GeneratingRuoyang Miao Shasha Li Protein Degradation and Inhibitors

Study details

DesignPreclinical chemical synthesis and in vitro…

InterventionCompound 11f, an HDTAC incorporating a hypo…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support